DSO National Laboratories and A*STAR's Diagnostics Development (DxD) Hub in Singapore have jointly developed RESOLUTE 2....
Equal Strategy, a leading sensory branding consultancy based in Singapore has launched a new business arm, Eco...
The Epstein-Barr virus (EBV), one of the most common human viruses is associated with about 8–10 per cent of stoma...
Singapore researchers have developed a unique and rapid SARS-CoV-2 surrogate virus neutralisation test (sVNT) to determi...
Singapore's Clinician innovators from SingHealth hospitals viz., KK Women’s and Children’s Hospital (KKH), S...
Singapore medical start-up Oncoshot is partnering with digital healthcare provider MyDoc, to give cancer patients access...
MP Biomedicals Asia Pacific Pte Ltd in collaboration with Singapore's A*STAR has developed ASSURE®&nb...
Singapore based startup Docquity, Southeast Asia's largest professional network of doctors, has partnered with...
Singapore has been ramping up its masks production capabilities since experiments have shown that wearing a ma...
US based Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the di...
Singapore based OMRON Asia Pacific, a global leader in industrial automation solutions across Asia Pacific, has forayed ...
Adolescents in academically competitive societies often fail to obtain adequate sleep on school-day nights. 85% of secon...
With the COVID-19 pandemic, Singapore’s healthcare system is faced with uncertainties and challenges includin...
SLINGSHOT 2020, powered by Startup SG, is now open for applications with over US$575,000 in prizes to be won! As one of...
Singapore-based surgical robotic firm NDR Medical Technology Pte Ltd today announced that it has raised SGD$8 million in...
A long-term research collaboration between A*STAR’s Genome Institute of Singapore (GIS) and the National Universit...
Two researchers from the National University of Singapore (NUS) who are members of the Intel Neuromorphic Research ...
The National Centre for Infectious Diseases (NCID) and A*STAR’s Singapore Immunology Network (SIgN) have announced...
